1,3,5-三(4-联苯基)苯
|
T405026-5g
|
≥98% |
6326-64-3 |
5g
|
¥ 1803.9
|
现货 |
阿拉丁 |
1,3,5-三(4-联苯基)苯
|
T405026-250mg
|
≥98% |
6326-64-3 |
250mg
|
¥ 190.9
|
现货 |
阿拉丁 |
反,反-4'-丙基双环己基-4-甲酸-3,4,5-三氟苯酯
|
T347052-5g
|
≥98% |
132123-45-6 |
5g
|
¥ 136.9
|
现货 |
阿拉丁 |
反,反-4'-丙基双环己基-4-甲酸-3,4,5-三氟苯酯
|
T347052-25g
|
≥98% |
132123-45-6 |
25g
|
¥ 502.9
|
现货 |
阿拉丁 |
反,反-4'-丙基双环己基-4-甲酸-3,4,5-三氟苯酯
|
T347052-100g
|
≥98% |
132123-45-6 |
100g
|
¥ 1609.9
|
现货 |
阿拉丁 |
4-(叔丁基)苯甲酰胺
|
T344455-5g
|
≥97% |
56108-12-4 |
5g
|
¥ 223.9
|
现货 |
阿拉丁 |
4-(叔丁基)苯甲酰胺
|
T344455-25g
|
≥97% |
56108-12-4 |
25g
|
¥ 913.9
|
现货 |
阿拉丁 |
曲普利啶 盐酸盐一水合物
|
T333593-5g
|
≥99% |
6138-79-0 |
5g
|
¥ 2014.9
|
现货 |
阿拉丁 |
曲普利啶 盐酸盐一水合物
|
T333593-250mg
|
≥99% |
6138-79-0 |
250mg
|
¥ 199.9
|
现货 |
阿拉丁 |
1,2,3,4-四氢-β-咔啉-1-羧酸
|
T331369-250mg
|
≥97% |
6649-91-8 |
250mg
|
¥ 448.9
|
现货 |
阿拉丁 |
1,2,3,4-四氢-β-咔啉-1-羧酸
|
T331369-1g
|
≥97% |
6649-91-8 |
1g
|
¥ 1168.9
|
现货 |
阿拉丁 |
1,2,3,4-四氢-β-咔啉-1-羧酸
|
T331369-100mg
|
≥97% |
6649-91-8 |
100mg
|
¥ 241.9
|
现货 |
阿拉丁 |
盐酸硫必利
|
T303838-5g
|
≥98% |
51012-33-0 |
5g
|
¥ 511.9
|
现货 |
阿拉丁 |
硫代磷酸三苯基异氰酸酯
|
T303680-1g
|
27% solution in ethyl acetate |
4151-51-3 |
1g
|
¥ 59.9
|
现货 |
阿拉丁 |
(R)-SITCP 配体
|
T282119-250mg
|
≥97% |
856407-37-9 |
250mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
6-对甲苯胺-2-萘磺酸钾盐(TNS-K +)
|
T275237-250mg
|
≥98% |
32752-10-6 |
250mg
|
¥ 699.9
|
现货 |
阿拉丁 |
6-对甲苯胺-2-萘磺酸钾盐(TNS-K +)
|
T275237-1g
|
≥98% |
32752-10-6 |
1g
|
¥ 1978.9
|
现货 |
阿拉丁 |
托美汀钠二水合物
|
T275047-100g
|
≥98% |
64490-92-2 |
100g
|
¥ 7599.9
|
现货 |
阿拉丁 |
三氯叔丁醇
|
T194001-5g
|
≥98% |
57-15-8 |
5g
|
¥ 29.9
|
现货 |
阿拉丁 |
三[4'-(2-噻吩基)-4-联苯基]胺
|
T162487-250mg
|
≥97% |
1092356-36-9 |
250mg
|
¥ 999.9
|
期货,请咨询 |
阿拉丁 |
DGAT-3
|
T139201-50mg
|
Moligand™, ≥98%(HPLC) |
701232-20-4 |
50mg
|
¥ 3199.9
|
现货 |
阿拉丁 |
DGAT-3
|
T139201-200mg
|
Moligand™, ≥98%(HPLC) |
701232-20-4 |
200mg
|
¥ 7999.9
|
现货 |
阿拉丁 |
DGAT-3
|
T139201-10mg
|
Moligand™, ≥98%(HPLC) |
701232-20-4 |
10mg
|
¥ 999.9
|
现货 |
阿拉丁 |
DGAT-3
|
T139201-100mg
|
Moligand™, ≥98%(HPLC) |
701232-20-4 |
100mg
|
¥ 4999.9
|
现货 |
阿拉丁 |